Hostname: page-component-7c8c6479df-nwzlb Total loading time: 0 Render date: 2024-03-29T14:10:23.482Z Has data issue: false hasContentIssue false

Closing the treatment gap for alcohol use disorders in low- and middle-income countries

Published online by Cambridge University Press:  09 December 2022

Abhijit Nadkarni*
Affiliation:
Centre for Global Mental Health, Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK Addictions Research Group, Sangath, Porvorim, India
Yashi Gandhi
Affiliation:
Addictions Research Group, Sangath, Porvorim, India
Urvita Bhatia
Affiliation:
Addictions Research Group, Sangath, Porvorim, India
Richard Velleman
Affiliation:
Addictions Research Group, Sangath, Porvorim, India Department of Psychology, University of Bath, Bath, UK
*
Corresponding author: Abhijit Nadkarni, E-mail: abhijit.nadkarni@lshtm.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

The alcohol-attributable disease burden is greater in low- and middle-income countries (LMICs) as compared to high-income countries. Despite the effectiveness of interventions such as health promotion and education, brief interventions, psychological treatments, family-focused interventions, and biomedical treatments, access to evidence-based care for alcohol use disorders (AUDs) in LMICs is limited. This can be explained by poor access to general health and mental health care, limited availability of relevant clinical skills among health care providers, lack of political will and/or financial resources, historical stigma and discrimination against people with AUDs, and poor planning and implementation of policies. Access to care for AUDs in LMICs could be improved through evidence-based strategies such as designing innovative, local and culturally acceptable solutions, health system strengthening by adopting a collaborative stepped care approach, horizontal integration of care into existing models of care (e.g., HIV care), task sharing to optimise limited human resources, working with families of individuals with AUD, and leveraging technology-enabled interventions. Moving ahead, research, policy and practice in LMICs need to focus on evidence-based decision-making, responsiveness to context and culture, working collaboratively with a range of stakeholders to design and implement interventions, identifying upstream social determinants of AUDs, developing and evaluating policy interventions such as increased taxation on alcohol, and developing services for special populations (e.g., adolescents) with AUDs.

Type
Overview Review
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Impact statement

Despite the huge burden of alcohol use and alcohol use disorders (AUDs) in terms of morbidity and mortality, access to appropriate and evidence-based care is limited. The treatment gap is particularly magnified in low- and middle-income countries (LMICs). Our review examines the size and causes of this large treatment gap in LMICs. More importantly, we identify innovative models of care that could be implemented in LMICs to reduce the treatment gap for AUDs. Finally, we end with a reflection on future perspectives which could shape research, policy and practice aimed at increasing access to evidence-based and contextually relevant care for AUDs in LMICs and other low-resource settings.

Social media summary

Critical ingredients 4 increasing access 2 care for those with drinking problems in developing world-evidence-based decision-making, cultural/contextual responsiveness of interventions designed & implemented collaboratively with key stakeholders & focuson policy interventions.

Introduction

The morbidity and mortality attributed to alcohol use is high across the world but vary considerably between regions and countries. The highest alcohol-attributable burden, estimated as disability-adjusted life years (DALYs) per 100,000 people, is in Eastern Europe and Southern sub-Saharan Africa (Degenhardt et al., Reference Degenhardt, Charlson, Ferrari, Santomauro, Erskine, Mantilla-Herrara, Whiteford, Leung, Naghavi and Griswold2018). The countries with the highest alcohol-attributable DALYs per 100,000 people include Russia, Ukraine, and Belarus in East Europe, and Lesotho, Central African Republic, and Burundi in sub-Saharan Africa (Degenhardt et al., Reference Degenhardt, Charlson, Ferrari, Santomauro, Erskine, Mantilla-Herrara, Whiteford, Leung, Naghavi and Griswold2018). However, in terms of absolute numbers, the highest alcohol-attributable DALYs are in East Asia, South Asia, Eastern Europe, and Tropical Latin America (Degenhardt et al., Reference Degenhardt, Charlson, Ferrari, Santomauro, Erskine, Mantilla-Herrara, Whiteford, Leung, Naghavi and Griswold2018).

Alcohol use disorders (AUDs) are commonly operationalised using the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD). They are characterised by impaired control over alcohol consumption resulting in continued, heavy, compulsive, and often escalating, alcohol use despite detrimental psychological, biological, behavioural, or social consequences for themselves, their family members and friends, and society in general (Carvalho et al., Reference Carvalho, Heilig, Perez, Probst and Rehm2019).

AUDs are widely prevalent, affecting 5.1% (95% CI 4.9–5.4) globally – 8.6% (95% CI 8.1–9.1) men and 1.7% (95% CI 1.6–1.9) women (World Health, 2018; Rehm and Shield, Reference Rehm and Shield2019). The prevalence of AUDs is highest in high-income countries (8.4%, 95% CI 8.0–8.9) and upper-middle-income countries (5.4%, 5.0–6.0) (World Health, 2018).

AUDs are associated with high morbidity and mortality; with the excess mortality associated with AUDs resulting in life expectancy that is lower by more than 20 years from the population average (Samokhvalov et al., Reference Samokhvalov, Popova, Room, Ramonas and Rehm2010; Westman et al., Reference Westman, Wahlbeck, Laursen, Gissler, Nordentoft, Hällgren, Arffman and Ösby2015; Schwarzinger et al., Reference Schwarzinger, Thiébaut, Baillot, Mallet and Rehm2018). Global DALYs attributable to alcohol use are highest for injuries (21.0 million DALYs), cardiovascular diseases (20.8 million DALYs), and cancers (14.8 million DALYs) (Degenhardt et al., Reference Degenhardt, Charlson, Ferrari, Santomauro, Erskine, Mantilla-Herrara, Whiteford, Leung, Naghavi and Griswold2018). Overall, 2.8 million deaths across the world in 2016 were attributed to alcohol use and AUDs (Degenhardt et al., Reference Degenhardt, Charlson, Ferrari, Santomauro, Erskine, Mantilla-Herrara, Whiteford, Leung, Naghavi and Griswold2018).

The leading causes of alcohol-associated deaths are cardiovascular disease, diabetes, injuries, gastrointestinal diseases, and cancers (World Health Organization, 2014). However, harms from alcohol use are not restricted only to health but comprise other domains of life such as violence, crime and loss of productivity (Martin, Reference Martin2001; Thavorncharoensap et al., Reference Thavorncharoensap, Teerawattananon, Yothasamut and Lertpitakpong2009). The global economic costs of alcohol consumption are estimated to be 1,306$ per adult or 2.6% of the GDP; and while 39% of these are incurred through direct costs (e.g., healthcare), the majority of costs are through indirect costs such as loss of productivity (61%; Manthey et al., Reference Manthey, Hassan, Carr, Kilian, Kuitunen-Paul and Rehm2021).

Even in high-income countries, alcohol use and AUDs lead to greater harm per litre of alcohol consumed in those from low socioeconomic strata compared to those from the high socioeconomic strata (Collins, Reference Collins2016). More specifically, individuals with a low socioeconomic status are at least twice as likely to die from heavy alcohol use than those with high socioeconomic status (Probst et al., Reference Probst, Roerecke, Behrendt and Rehm2015). This is particularly important for low- and middle-income countries (LMICs) where a significantly large proportion of the population resides in impoverished conditions.

There is good evidence of a range of psychosocial and pharmacological interventions for effective treatment of AUDs in a variety of settings (Carvalho et al., Reference Carvalho, Heilig, Perez, Probst and Rehm2019). In addition, evidence from high-income countries indicates that alcohol control policies of restricting availability, banning marketing, and increasing taxation are highly cost-effective in reducing alcohol-attributable harm (Carvalho et al., Reference Carvalho, Heilig, Perez, Probst and Rehm2019). It is estimated that increasing access to treatment within primary care settings for 30% of heavy-drinking patients could decrease the overall prevalence of harmful use of alcohol by 10–15% and reduce the incidence of AUD by 5–14% (Sassi, Reference Sassi2015). Similarly, if the proportion of patients with AUD who received treatment doubled, the annual incidence of AUD would decrease to between 1 and 4% (Sassi, Reference Sassi2015). Finally, if 60% of people with AUD were treated with effective interventions, approximately 13% of male and 9% of female alcohol-attributable deaths would be averted in a 12-month period (Rehm et al., Reference Rehm, Shield, Gmel, Rehm and Frick2013).

With alcohol consumption stabilising or reducing in developed countries, transnational corporations have identified LMICs for sales growth, and hence it is expected that both overall consumption and harmful drinking will rise in such countries. For example, the African continent is seen as a major opportunity for market expansion as almost 70% of the adult population is abstinent, and hence there are expected increases in the number of potential new alcohol consumers, especially young people and women (World Health Organization, 2014; Toesland, Reference Toesland2016). Hence, the aim of this paper is to focus on LMICs to examine the burden of AUDs, the magnitude of the treatment gap, key contributors to the treatment gap, the existing health systems response to the treatment gap, and innovative solutions to reduce the treatment gap. In the following sections, each one of these objectives is discussed in greater detail.

Burden of AUDs in LMICs

There is a moderately negative relation between gross national income (GNI) and amount of harm caused due to alcohol (World Health, 2018). In other words, the alcohol-attributable disease burden is found to be greater in LMICs as compared to high-income countries. The age-standardised alcohol-attributable burden of disease and injury is highest in Africa (70.6 deaths and 3,044 DALYs per 100,000) although alcohol consumption is highest in the European region (World Health, 2018). The consumption patterns are different as well – alcohol is consumed mostly by younger men (83%) in LMICs like Belarus, Brazil, Mexico and India, compared to middle-aged men and women in HICs (Smyth et al., Reference Smyth, Teo, Rangarajan, O’Donnell, Zhang, Rana, Leong, Dagenais, Seron and Rosengren2015; World Health, 2018).

There are geographical variations within LMICs as well. The BRICS (Brazil–Russia–India–China–South Africa) countries are some of the world’s largest countries, both with regard to population size and land coverage. From 1990 to 2013, there was an overall decrease of alcohol-attributable age-standardised DALYs in Brazil, China and South Africa, and an overall increase in Russia and India (Rabiee et al., Reference Rabiee, Agardh, Coates, Allebeck and Danielsson2017).

There is also evidence on the role of socioeconomic factors on harmful drinking patterns even within LMICs. In South Africa, high-income earners had the highest drinking prevalence but low-income earners consumed more alcohol on average, spent a greater proportion of household income on alcohol and experienced a higher burden of alcohol-related harm (Walls et al., Reference Walls, Cook, Matzopoulos and London2020). Furthermore, in South Africa, 60% of all alcohol-attributable deaths occurred in the lower 30% of the socioeconomic distribution (World Health, 2018).

Overall, the premature mortality rate is disproportionately higher in LMICs with more than 85% of all deaths attributable to alcohol occurring in these countries. This is partly because of riskier patterns of consumption, and the lack of safe ‘built’ environments like roads which increases the risk of injuries in these countries (Patel et al., Reference Patel, Chisholm, Dua, Laxminarayan and Medina-Mora2016). The alcohol-attributable burden of disease is also greater in LMICs due to the larger burden caused by associated conditions such as tuberculosis, cardiovascular diseases, interpersonal violence, self-harm and poisoning, and unintentional injuries (Patel et al., Reference Patel, Chisholm, Dua, Laxminarayan and Medina-Mora2016; World Health, 2018). While this is true worldwide, its burden and impact are more pronounced in LMICs primarily since these behaviours are linked to AUDs which are rarely identified within the primary health care system. Moreover, while the rates of alcohol consumption among women in LMICs are lower, they suffer from disproportionately greater social consequences per litre consumed due to cultural norms (Patel et al., Reference Patel, Chisholm, Dua, Laxminarayan and Medina-Mora2016). Overall, the health and societal costs accrued due to alcohol consumption outweigh any economic benefits resulting from the alcohol industry in LMICs (Patel et al., Reference Patel, Chisholm, Dua, Laxminarayan and Medina-Mora2016).

Interventions for AUDs

The evidence about treatment interventions for AUDs in LMICs is limited and summarised in this section. In this section, we will briefly summarise universal interventions such as health promotion, brief interventions (BIs), psychological treatments, family interventions, and biomedical treatments. Some of these interventions have been described in much more detail in other reviews which can supplement some of the evidence presented in our review (Joseph and Basu, Reference Joseph and Basu2017; Sileo et al., Reference Sileo, Miller, Wagman and Kiene2021; Ghosh et al., Reference Ghosh, Singh, Das, Pandit, Das and Sarkar2022; Staton et al., Reference Staton, Vissoci, El-Gabri, Adewumi, Concepcion, Elliott, Evans, Galson, Pate and Reynolds2022).

Health promotion and education

Although several RCTs have evaluated health promotion and education interventions in a range of settings such as the workplace, the community, schools, and clinics (Kalichman et al., Reference Kalichman, Simbayi, Vermaak, Cain, Smith, Mthebu and Jooste2008; Chhabra et al., Reference Chhabra, Springer, Leu, Ghosh, Sharma and Rapkin2010; Cubbins et al., Reference Cubbins, Kasprzyk, Montano, Jordan and Woelk2012; Aira et al., Reference Aira, Wang, Riedel and Witte2013; Bolton et al., Reference Bolton, Lee, Haroz, Murray, Dorsey, Robinson, Ugueto and Bass2014; Marsiglia et al., Reference Marsiglia, Kulis, Booth, Nuño-Gutierrez and Robbins2015; Rotheram-Borus et al., Reference Rotheram-Borus, Tomlinson, Le Roux and Stein2015; Chaudhury et al., Reference Chaudhury, Brown, Kirk, Mukunzi, Nyirandagijimana, Mukandanga, Ukundineza, Godfrey, Ng and Brennan2016; Jordans et al., Reference Jordans, Luitel, Garman, Kohrt, Rathod, Shrestha, Komproe, Lund and Patel2019), a majority of the programs addressed alcohol use in the context of HIV/AIDS prevention and risk reduction (Kalichman et al., Reference Kalichman, Simbayi, Vermaak, Cain, Smith, Mthebu and Jooste2008; Chhabra et al., Reference Chhabra, Springer, Leu, Ghosh, Sharma and Rapkin2010; Cubbins et al., Reference Cubbins, Kasprzyk, Montano, Jordan and Woelk2012). Some of these studies reported positive results (Kalichman et al., Reference Kalichman, Simbayi, Vermaak, Cain, Smith, Mthebu and Jooste2008; Aira et al., Reference Aira, Wang, Riedel and Witte2013; Marsiglia et al., Reference Marsiglia, Kulis, Booth, Nuño-Gutierrez and Robbins2015; Chaudhury et al., Reference Chaudhury, Brown, Kirk, Mukunzi, Nyirandagijimana, Mukandanga, Ukundineza, Godfrey, Ng and Brennan2016), while others had mixed results, that is, change in some outcomes and not in others or an initial reduction in alcohol use followed by a relapse (Aira et al., Reference Aira, Wang, Riedel and Witte2013; Rotheram-Borus et al., Reference Rotheram-Borus, Tomlinson, Le Roux and Stein2015).

Brief interventions

BIs are generally characterised by a few short sessions involving an assessment of individual risk with feedback and advice, followed by provision of structured advice, or brief motivational interviewing that takes a more patient-centred approach, or a combination of both (Heather, Reference Heather2010). BIs are the most tested interventions for AUDs in LMICs, most commonly using motivational interviewing techniques (Pengpid et al., Reference Pengpid, Peltzer, Van der Heever and Skaal2013; Signor et al., Reference Signor, Pierozan, Ferigolo, Fernandes, Mazoni and Barros2013; Ward et al., Reference Ward, Mertens, Bresick, Little and Weisner2015; Kamal et al., Reference Kamal, Sunita, Karobi and Abhishek2020); delivered by non-specialist health workers (NSHWs; Noknoy et al., Reference Noknoy, Rangsin, Saengcharnchai, Tantibhaedhyangkul and McCambridge2010; Mertens et al., Reference Mertens, Ward, Bresick, Broder and Weisner2014) or through digital platforms (Baldin et al., Reference Baldin, Sanudo and Sanchez2018; Bedendo et al., Reference Bedendo, Ferri, de Souza, Andrade and Noto2019). There is substantial evidence on the effectiveness of BIs on a range of short- and long-term drinking outcomes, in healthcare and community settings, in men as well as women, and when delivered by NSHWs, or digitally (Noknoy et al., Reference Noknoy, Rangsin, Saengcharnchai, Tantibhaedhyangkul and McCambridge2010; Pengpid et al., Reference Pengpid, Peltzer, Van der Heever and Skaal2013; de Oliveira Christoff and Boerngen-Lacerda, Reference de Oliveira Christoff and Boerngen-Lacerda2015; Bedendo et al., Reference Bedendo, Ferri, de Souza, Andrade and Noto2019, Reference Bedendo, McCambridge, Gaume, Souza, Formigoni and Noto2020; Wechsberg et al., Reference Wechsberg, Bonner, Zule, van der Horst, Ndirangu, Browne, Kline, Howard and Rodman2019). Compared to a range of other public health policies designed to reduce alcohol-related harm (e.g., regulation of alcohol advertising) BIs achieve larger effects as measured by DALYs (Franco, Reference Franco2015).

Psychological treatments

Compared to BIs, the evidence about psychological treatments (brief or extended) for AUDs in LMICs is limited. Most of the existing evidence is about interventions based on motivational interviewing techniques or cognitive behavioural therapy (CBT) delivered to participants in a range of settings such as hospitals, emergency departments, primary care, and specialist clinics for patients with HIV or tuberculosis (Nattala et al., Reference Nattala, Leung, Nagarajaiah and Murthy2010; Shin et al., Reference Shin, Livchits, Connery, Shields, Yanov, Yanova, Fitzmaurice, Nelson, Greenfield and Group2013; Daengthoen et al., Reference Daengthoen, Saengcharnchai, Yingwiwattanapong and Perngparn2014; Nadkarni et al., Reference Nadkarni, Weobong, Weiss, McCambridge, Bhat, Katti, Murthy, King, McDaid, Park, Wilson, Kirkwood, Fairburn, Velleman and Patel2017b; Papas et al., Reference Papas, Gakinya, Mwaniki, Lee, Keter, Martino, Klein, Liu, Loxley, Sidle, Schlaudt, Nafula, Omodi, Baliddawa, Kinyanjui and Maisto2021). Most randomised controlled trials (RCTs) demonstrate the effectiveness of interventions such as combination therapy, dyadic intervention, motivational interviewing with or without problem-solving, and CBT (Nattala et al., Reference Nattala, Leung, Nagarajaiah and Murthy2010; Rendall‐Mkosi et al., Reference Rendall‐Mkosi, Morojele, London, Moodley, Singh and Girdler‐Brown2013; Daengthoen et al., Reference Daengthoen, Saengcharnchai, Yingwiwattanapong and Perngparn2014; Sorsdahl et al., Reference Sorsdahl, Stein, Corrigall, Cuijpers, Smits, Naledi and Myers2015; Madhombiro et al., Reference Madhombiro, Kidd, Dube, Dube, Mutsvuke, Muronzie, Zhou, Derveeuw, Chibanda and Chingono2020; Papas et al., Reference Papas, Gakinya, Mwaniki, Lee, Keter, Martino, Klein, Liu, Loxley, Sidle, Schlaudt, Nafula, Omodi, Baliddawa, Kinyanjui and Maisto2021).

BIs and psychological treatments could be conceptualised as lying on a continuum of care. They can be distinguished from each other based on several criteria, including the outcomes they try to achieve. For example, BIs are generally focused on motivating the drinker to initiate change (e.g., enter treatment) while psychological treatments address larger concerns (e.g., addressing long-standing problems that exacerbate alcohol use) (Center for Substance Abuse Treatment, 1999). Other characteristics that might distinguish them include the number and duration of the sessions (fewer and shorter sessions for BIs), delivery settings (non-traditional treatment settings such as a social service or primary care), and delivery agents (BIs delivered by non-specialists; Center for Substance Use Treatment, 1999).

Family-focused interventions

Traditionally, family members have been neglected in addictions services, with the focus of treatments largely being limited to engaging the person with drinking problems (Orford et al., Reference Orford, Velleman, Natera, Templeton and Copello2013). Over the years, a number of psychotherapeutic approaches have been designed and evaluated where family members are engaged jointly with the person with drinking problems, or in their own right. A recent meta-analysis highlighted the effectiveness of psychosocial interventions directed at affected family members in improving clinical, health and relationship outcomes in family members and treatment engagement in the person with AUD (Merkouris et al., Reference Merkouris, Rodda and Dowling2022).

Biomedical treatments

Some RCTs evaluated biomedical treatments such as medications (e.g., naltrexone, gabapentin, disulfiram, and topiramate), combined behavioural and medication interventions (e.g., acamprosate with Alcoholics Anonymous, baclofen with a BI), and brain stimulation. Naltrexone had a limited impact on drinking outcomes (Ahmadi et al., Reference Ahmadi, Babaeebeigi, Maany, Porter, Mohagheghzadeh, Ahmadi and Dehbozorgi2004; Shin et al., Reference Shin, Livchits, Connery, Shields, Yanov, Yanova, Fitzmaurice, Nelson, Greenfield and Group2013), topiramate had mixed results (Baltieri et al., Reference Baltieri, Daró, Ribeiro and De Andrade2008; Likhitsathian et al., Reference Likhitsathian, Uttawichai, Booncharoen, Wittayanookulluk, Angkurawaranon and Srisurapanont2013), and gabapentin, acamprosate, and baclofen showed positive results (Furieri and Nakamura-Palacios, Reference Furieri and Nakamura-Palacios2007; Baltieri et al., Reference Baltieri, Daró, Ribeiro and De Andrade2008; Gupta et al., Reference Gupta, Verma, Rastogi, Arora and Elwadhi2017). The few studies that tested the effectiveness of transcranial direct current stimulation (all in Brazil) showed mixed results with some studies reporting positive reports (Boggio et al., Reference Boggio, Sultani, Fecteau, Merabet, Mecca, Pascual-Leone, Basaglia and Fregni2008; da Silva et al., Reference da Silva, Conti, Klauss, Alves, do Nascimento Cavalcante, Fregni, Nitsche and Nakamura-Palacios2013), and others with positive effects on some outcomes and not on others (Klauss et al., Reference Klauss, Penido Pinheiro, Silva Merlo, Correia Santos, Fregni, Nitsche and Miyuki Nakamura-Palacios2014).

Treatment gap in LMICs

Treatment gap refers to the proportion of individuals who require treatment for a particular condition but do not receive it; and this is an important metric of the inequitable supply of services and the presence of disparities in both the needs and demands for treatment (Patel et al., Reference Patel, Maj, Flisher, De Silva, Koschorke, Prince, Zonal, Representatives, Tempier, Riba and Sanchez2010). Globally the treatment gap for people with mental disorders represents a major public health challenge as demonstrated by data from community surveys in 25 countries in the WHO World Mental Health Survey Initiative (Kessler et al., Reference Kessler, Aguilar-Gaxiola, Alonso, Chatterji, Lee and Üstün2009). Only 14% of individuals with mental disorders in lower-middle-income countries, 22% in upper-middle-income countries, and 37% in high-income countries received treatment (Evans-Lacko et al., Reference Evans-Lacko, Aguilar-Gaxiola, Al-Hamzawi, Alonso, Benjet, Bruffaerts, Chiu, Florescu, de Girolamo and Gureje2018). The highest treatment rate (18%) was in the general medical sector followed by the specialist mental health sector (14%); while the treatment rates were much lower in the human services sector (e.g., religious or spiritual advisor, social worker) and complementary alternative medicine sector (4% each) (Evans-Lacko et al., Reference Evans-Lacko, Aguilar-Gaxiola, Al-Hamzawi, Alonso, Benjet, Bruffaerts, Chiu, Florescu, de Girolamo and Gureje2018).

Despite the high burden of AUDs and availability of evidence-based interventions, outlined above, access to appropriate treatment remains low. The pooled treatment rate of AUD from any source of treatment is 17.3% (95% CI 12.8–22.3), that is, a treatment gap of 82.7% (Mekonen et al., Reference Mekonen, Chan, Connor, Hall, Hides and Leung2021). This effectively means that four out of five individuals with AUD do not have access to appropriate care for their drinking problems. The treatment rate varies widely between countries – 3.5% in Uganda to 51.8% in the United Kingdom; and overall the treatment rate of 9.3% (95% CI: 4.0–15.7%) in LMICs is much lower than the overall global figure (Mekonen et al., Reference Mekonen, Chan, Connor, Hall, Hides and Leung2021).

Similarly, despite the evidence about the effectiveness of a range of interventions for AUDs in LMICs, the ‘treatment gap’ remains substantial. Mental Health Care Gap is proposed as a more comprehensive measure to describe access to care as this encompasses ‘treatment gap’, ‘psychosocial care gap’ (lack of psychosocial interventions), and ‘physical health care gap’ (lack of or substandard provision of physical health interventions) (Pathare et al., Reference Pathare, Brazinova and Levav2018). However, in the absence of reliable estimates of this new metric, we will focus on the conventional treatment gap to illustrate poor access to care for AUDs in LMICs.

Research on the treatment gap for AUDs in LMICs is limited, but sufficient to conclude that overall a very small proportion of people with AUDs have access to relevant care and this varies between countries. In a study that conducted health-facility-based cross-sectional studies in five LMIC districts, among participants who screened positive for AUD, clinical detection of AUD ranged from 0% in Ethiopia and India to 7.8% in Nepal (Rathod et al., Reference Rathod, Roberts, Medhin, Murhar, Samudre, Luitel, Selohilwe, Ssebunnya, Jordans and Bhana2018). Additionally, treatment access was 0% in all those countries except Nepal, where it was 2.2% (Rathod et al., Reference Rathod, Roberts, Medhin, Murhar, Samudre, Luitel, Selohilwe, Ssebunnya, Jordans and Bhana2018). In the same study, contact with any kind of relevant (but not necessarily evidence-based) treatment over the past 12 months (‘contact coverage’), for adults with probable AUDs, ranged from 2.8% in India to 5.1% in Nepal (Rathod et al., Reference Rathod, De Silva, Ssebunnya, Breuer, Murhar, Luitel, Medhin, Kigozi, Shidhaye and Fekadu2016); and in Ethiopia, lifetime contact coverage for probable AUD was 13.1% (Rathod et al., Reference Rathod, De Silva, Ssebunnya, Breuer, Murhar, Luitel, Medhin, Kigozi, Shidhaye and Fekadu2016). Finally, relatively older data indicates that the treatment gap for AUDs was high in LMICs such as Brazil (53.3%), Mexico (93.8%), and Turkey (89.8%) (Kohn et al., Reference Kohn, Saxena, Levav and Saraceno2004). Although this data is relatively old, there is nothing to indicate that these treatment gaps would have decreased substantially over the years.

Contributors to the treatment gap in LMICs

The treatment gap may be explained by some combination of (1) limited access to general health and mental health care, (2) poor accessibility of evidence-based treatments, (3) limited availability of and clinical skills among health care providers, (4) lack of political will and/or financial resources, (5) historical stigma and discrimination against people with AUDs, and (6) poor planning and implementation of policies (Connery et al., Reference Connery, McHugh, Reilly, Shin and Greenfield2020).

Stigma towards people with AUDs contributes to marginalisation of such individuals, self-stigma, avoidance of help-seeking, social isolation, and lack of awareness among policymakers and clinicians about the availability of effective treatments (Connery et al., Reference Connery, McHugh, Reilly, Shin and Greenfield2020). The relationship between stigma towards people with AUDs and help-seeking has not been extensively studied in LMICs. The available evidence shows that there is a high internalised stigma experienced by those with AUD and the fear of being labelled an ‘alcoholic’ leads to low utilisation of treatment services, since it confirms their membership of the stigmatised group (Zewdu et al., Reference Zewdu, Hanlon, Fekadu, Medhin and Teferra2019). Research from India and Uganda indicates that, people with AUDs feel disappointed with themselves, feel embarrassed and ashamed, believe that others think that they cannot achieve much in life because of their alcohol problems, are ignored by people or taken less seriously because of their problems, and feel out of place in the world (Rathod et al., Reference Rathod, Nadkarni, Bhana and Shidhaye2015; Nalwadda et al., Reference Nalwadda, Rathod, Nakku, Lund, Prince and Kigozi2018); all of which could result in a reluctance to access help. Other common factors that might hinder service utilisation include low perceived needs, lack of awareness about the available services, inability to afford the treatment cost, and limited access to effective treatments (Edlund et al., Reference Edlund, Unützer and Curran2006; Saraceno et al., Reference Saraceno, van Ommeren, Batniji, Cohen, Gureje, Mahoney, Sridhar and Underhill2007; Luitel et al., Reference Luitel, Jordans, Kohrt, Rathod and Komproe2017).

In most LMICs, interventions for AUDs are expected to be delivered by mental health care workers. However, estimates in 2005 indicate that there was a shortage of 1.2 million mental health workers (Kakuma et al., Reference Kakuma, Minas, van Ginneken, Dal Poz, Desiraju, Morris, Saxena and Scheffler2011) in LMICs, and there have not been any drastic systemic changes over the years to indicate that this shortfall might have reduced significantly. In such circumstances, primary care practitioners can potentially be frontline providers of care for those with AUDs. However, challenges in primary care that pose barriers to delivering AUD care in LMICs include limited training, high clinical workload, competing clinical priorities, and perceived complexity of interventions for AUDs (Myers et al., Reference Myers, Stein, Mtukushe and Sorsdahl2012; Rathod et al., Reference Rathod, Pinninti, Irfan, Gorczynski, Rathod, Gega and Naeem2017; Ronzani et al., Reference Ronzani, Fuentes-Mejía, Mota, Gomide, Ferreira and Cruvinel2019).

Finally, explanatory models of ill health are closely linked to the cultural context (Jacob and Patel, Reference Jacob and Patel2014). Additionally, access to appropriate care is mediated by cultural practices and traditions, which might sometimes prevent people from accessing treatment (Bracke et al., Reference Bracke, Delaruelle and Verhaeghe2019). Interventions which are not relevant to the context and do not incorporate the nature of the social, economic and cultural environment might not be acceptable and hence not effective in reducing the treatment gap.

Health system response

The costs to plug the gaps in the health systems to increase access to care for AUD are not substantial. For example, a package that will achieve coverage levels of 80% of cases with psychosis and bipolar disorder, and a modest 25–33% of cases with depression and risky drinking would cost only 2$ per capita in low-income countries, and 3–4$ in middle-income countries (Levin and Chisholm, Reference Levin and Chisholm2016). Another estimate calculated that the annual cost of delivering a package of interventions for schizophrenia, depression, epilepsy, and AUDs in Sub-Saharan Africa and South Asia would be 3–4$ per capita (Levin and Chisholm, Reference Levin and Chisholm2016).

However, the size and character of models of care for AUD that a country adopts depend on how it views the alcohol problems in its population and its reliance on alcohol-related revenue, rather than on cost-effectiveness of the model, the treatment requirements of the country, and the availability of economic resources (Babor et al., Reference Babor, Stenius and Romelsjo2008). In many LMICs, the service models adopted for AUDs are mainly organised around tertiary care interventions, focus only on treatment of alcohol dependence, and have a disproportionate emphasis on long-term residential rehabilitation, specialised clinics, and psychiatric hospitals (Perngparn et al., Reference Perngparn, Assanangkornchai, Pilley and Aramrattana2008). Even these services are poorly accessible as they are inequitably distributed, primarily situated in urban areas, and often run by private providers charging fees which are unlikely to be affordable to all. Most people with early alcohol-related problems consult primary health care clinicians, mostly for physical health problems related to alcohol use. However, in the absence of routine screening for AUD in primary care and lack of training to recognise the problem, most people with AUDs in LMICs remain untreated for over a decade (Benegal et al., Reference Benegal, Chand and Obot2009). In summary, in many LMICs, prevention in earlier stages of problem drinking is mostly non-existent and alcohol-related problems are first addressed when they are already severe and difficult to treat.

Innovations to improve access to care for AUDs in LMICs

Designing local and culturally acceptable solutions

Besides individual risk factors for AUD (e.g., male gender, lower education level, unemployment), there are critical contextual forces such as availability of alcohol, alcohol advertising, policies related to alcohol availability, and norms around drinking, that shape drinking behaviours (Gruenewald et al., Reference Gruenewald, Ponicki and Holder1993; Alaniz, Reference Alaniz1998; Borsari and Carey, Reference Borsari and Carey2001; Gruenewald et al., Reference Gruenewald, Remer and Lipton2002). Hence, bridging the treatment gap will require making strategic choices about evidence-based treatments after suitable adaptation to suit the context, and special attention being paid to local patterns of drinking and its intersection with cultural influences (e.g., boatmen of Benares in India, while averse to any public displays of drunkenness on the sacred ghats recognise alcohol as a legitimate source of relaxation [Doron, Reference Doron2010]), and existing health systems. This requires a detailed landscaping of the context and this could be achieved through a situational analysis involving key stakeholders who will be able to provide critical information about which interventions will be acceptable, and also on implications for delivery. Such a participatory exercise affords additional advantages such as reduction of stigma and promoting buy-in through dialogue about concerns and potential solutions to address them. It also allows to pre-empt potential barriers which could consign a new initiative to failure. For example, pharmacologic interventions may not be best suited for settings with weak supply chains, and the choice of psychological treatments will depend on acceptability of ‘talking treatments’ to the target group, as well as systemic considerations such as the number and skills of health care providers. Although existing evidence is limited, culturally adapted interventions for AUDs are a promising approach for reducing alcohol use and related consequences with a demonstrated effect size of 0.25 (95% CI 0.08, 0.43) (Hai et al., Reference Hai, Lee, Abbas, Bo, Morgan and Delva2021). Case study 1 is an example of the importance of contextual adaptations to make program relevant to the settings in which it is being delivered.

Case study 1: The Healthy Women Healthy Living (HWHL) is an intervention developed for reducing heavy drinking in women living with HIV in the US. The HWHL was adapted for use in Uganda (Leddy et al., Reference Leddy, Hahn, Getahun, Emenyonu, Woolf-King, Sanyu, Katusiime, Fatch, Chander and Hutton2021) through identification of core intervention elements to be retained, and ‘surface structure’ adaptations of the content, focus group discussions with key stakeholders including patients, and cognitive interviews with patients and patient helpers. This process resulted in adaptations to account for varying literacy levels in the setting, acknowledgement of motivations for reducing alcohol consumption that include salient concepts such as retaining the respect of family, shifting of focus from alcohol use in one’s home to reflect the social nature of drinking and peer pressure to drink in Uganda, and inclusion of culturally relevant behavioural strategies to reduce alcohol use, such as drinking tea instead of alcohol.

Several models have been proposed to guide contextual adaptations to complex interventions and they appear to have several convergence points (Barrera and Castro, Reference Barrera and Castro2006; McKleroy et al., Reference McKleroy, Galbraith, Cummings, Jones, Harshbarger, Collins, Gelaude and Carey2006; Kumpfer et al., Reference Kumpfer, Pinyuchon, de Melo and Whiteside2008; Wingood and DiClemente, Reference Wingood and DiClemente2008; Nadkarni et al., Reference Nadkarni, Velleman, Dabholkar, Shinde, Bhat, McCambridge, Murthy, Wilson, Weobong and Patel2015). The defining feature of these models is that they integrate existing theory and procedures (‘top-down’ elements), with input from contextually relevant stakeholder groups (‘bottom-up’ elements) to arrive at an adapted version that can then be rigorously evaluated.

Health system strengthening

Many people with AUDs do not come into contact with addiction services, until the condition is severe. Hence, interventions need to be made available through alternative delivery platforms to reach those individuals who are not accessing routine healthcare systems. Such an integration requires buy-in from a range of relevant stakeholders and would involve sensitisation of leaders and front-line providers from such programs to the relevance of treating AUDs and of embracing accountability for individuals with AUDs who are traditionally excluded from health care. Thus, reducing the treatment gap for AUDs requires multidisciplinary effort with specialists such as psychiatrists and psychologists, working collaboratively with primary care providers, healthcare teams focused on medical conditions commonly co-occurring with AUDs, community-based health and social workers, and peer and lay counsellors.

The general principles guiding such health system strengthening include designing the program through participatory planning with multiple stakeholders, using contextually relevant screening tools for early identification of AUDs in routine care, training health and other workers in the use of manualised and brief low-intensity psychological interventions, providing supervision and support, and rapidly responding to natural opportunities in which political will or funding can be leveraged to strengthen AUD care (Davies and Lund, Reference Davies and Lund2017).

Collaborative stepped care is one such health system-strengthening approach which enhances health system efficiency in patients with complex and chronic problems such as AUDs (Kodner and Spreeuwenberg, Reference Kodner and Spreeuwenberg2002). In such an approach, patients start treatment with low-intensity, low-cost interventions, and, guided by systematically monitored treatment outcomes, move to a higher-intensity treatment only if necessary. This allows for maximising efficiency by deploying limited resources according to need, and reserving highly specialised, intensive, and expensive resources for those with the most complex or severe problems.

The collaborative stepped-care approach has been most successfully used in high-income countries for treating common mental disorders in primary care, with some evidence from LMICs such as India (Archer et al., Reference Archer, Bower, Gilbody, Lovell, Richards, Gask, Dickens and Coventry2012). In addition to such evidence from highly controlled research studies, there are case studies from LMICs such as Brazil and India which demonstrate successful real-world implementation of the collaborative stepped-care approach for provision of mental healthcare (Shidhaye et al., Reference Shidhaye, Lund and Chisholm2015). Case study 2 describes a program designed to increase access to care for AUD through task-sharing with lay-counsellors based in primary care settings.

Case study 2: Counselling for alcohol problems (CAP) is an example of a contextually adapted brief psychological treatment for harmful drinking that is designed to be delivered through task-sharing with non-specialist health workers in primary care settings. CAP is a 3-phase treatment delivered over 1 to 4 sessions based on a motivational interviewing stance and involves the following strategies: assessment and personalised feedback, family engagement, drink refusal skills, skills to address drinking urges, problem-solving skills and handling difficult emotions, and relapse prevention and management (Nadkarni et al., Reference Nadkarni, Velleman, Dabholkar, Shinde, Bhat, McCambridge, Murthy, Wilson, Weobong and Patel2015). CAP was tested in a trial in India and was found to be superior to enhanced usual care in reducing drinking (Nadkarni et al., Reference Nadkarni, Weiss, Weobong, McDaid, Singla, Park, Bhat, Katti, McCambridge, Murthy, King, Wilson, Kirkwood, Fairburn, Velleman and Patel2017a,Reference Nadkarni, Weobong, Weiss, McCambridge, Bhat, Katti, Murthy, King, McDaid, Park, Wilson, Kirkwood, Fairburn, Velleman and Patelb). It was also found to be cost-effective, which makes it a potentially key strategy to reduce the treatment gap for AUD.

There is no reason why these successful models could not be extended to AUDs by systematic identification in primary care, close involvement of patients in joint decision-making regarding their care, development of a holistic care plan that includes psychological interventions, social care, and medication management where appropriate, streamlined referral pathways, regular and planned monitoring of patients, and consultation with specialists for patients who do not show clinical improvement.

Horizontal integration of care into existing models of care

In many global health settings, there are existing robust healthcare delivery platforms that are potentially well-suited to integrate AUD identification and treatment. These include programs such as those for HIV and TB which are a natural fit for layering on treatments for AUD because of the strong causal relationships between these conditions. Additionally, such communicable diseases programs are typically high on the priority agenda even in LMICs and hence there is already existing strong buy-in from policymakers. Integrating AUD interventions into these existing healthcare platforms helps leverage available health systems such as medication supply chains and health worker cadres (Shidhaye et al., Reference Shidhaye, Lund and Chisholm2015). Case study 3 describes the efficient use of limited resources through the integration of AUD care in an existing program which provides services for a clinical condition which is strongly associated with AUDs.

Case study 3: A culturally adapted cognitive-behavioural therapy (CBT) intervention was integrated into an HIV outpatient clinic in Kenya. It was delivered by paraprofessional counsellors to HIV-positive patients with heavy drinking. The intervention was delivered over six sessions and included analysis of behaviour, skills for coping with triggers, urges and high–risk situations, identifying risky decisions leading to drinking, problem-solving skills, drink refusal skills, and relapse prevention strategies (Papas et al., Reference Papas, Sidle, Martino, Baliddawa, Songole, Omolo, Gakinya, Mwaniki, Adina and Nafula2010). The CBT intervention was found to be superior to healthy lifestyle education in reducing alcohol use (Papas et al., Reference Papas, Gakinya, Mwaniki, Lee, Keter, Martino, Klein, Liu, Loxley, Sidle, Schlaudt, Nafula, Omodi, Baliddawa, Kinyanjui and Maisto2021).

The success of the collaborative stepped care model and horizontal integration of care into existing health care systems, described above, hinges on a ‘case manager’ who is responsible for coordinating care and who forms the critical link between patients, their families, primary care, and specialist health services (Patel et al., Reference Patel, Weiss, Chowdhary, Naik, Pednekar, Chatterjee, De Silva, Bhat, Araya, King, Simon, Verdeli and Kirkwood2010). Such a resource does not routinely exist in low-resource settings and funding needs to be leveraged for identifying appropriate individuals and building their capacities to play such a role.

Task sharing to optimise limited human resources

Task-sharing is a human resource innovation which involves strategic redistribution of some specialist tasks to appropriately trained and supervised non-specialist workers to increase access to evidence-based care through efficient use of limited resources (Shifting, Reference Shifting2008). Given the shortage of specialist healthcare workers and the high workload on existing primary care services in LMICs, access to care for AUD necessitates task-sharing with non-medical lay staff, community stakeholders as well as family members. Evidence from LMICs demonstrates that task-sharing is effective in supporting recovery from depression and anxiety, reducing symptoms of perinatal depression, reducing symptoms of adults with post-traumatic stress disorder, improving day-to-day functioning of people with schizophrenia, improving the behavioural symptoms of people with dementia and the mental well-being, burden and distress of carers of people with dementia (van Ginneken et al., Reference van Ginneken, Chin, Lim, Ussif, Singh, Shahmalak, Purgato, Rojas-García, Uphoff, McMullen, Foss, Pachya, Rashidian, Borghesani, Henschke, Chong and Lewin2021).

Trained non-specialist workers can play a crucial role in identifying, engaging with, and building awareness in individuals with AUDs and their family members, maintaining follow-up, ensuring adherence, monitoring clinical outcomes, and delivering low-intensity, evidence-based, first-line psychological treatments such as motivational interviewing (van Ginneken et al., Reference van Ginneken, Chin, Lim, Ussif, Singh, Shahmalak, Purgato, Rojas-García, Uphoff, McMullen, Foss, Pachya, Rashidian, Borghesani, Henschke, Chong and Lewin2021). Building successful task-sharing models requires the identification of shared needs and goals, mutual and respectful engagement, robust training and ongoing supervision in evidence-based treatment protocols, and quality control through monitoring and iterative feedback loops to optimise services. Although this requires intensive front-loading of resources, in the longer term it results in significant gains in increasing access to sustainable evidence-based care. Evidence on task-shared interventions for AUDs in LMICs is growing and indicates their effectiveness in reducing risk of, and increasing recovery from, hazardous and harmful alcohol use (van Ginneken et al., Reference van Ginneken, Chin, Lim, Ussif, Singh, Shahmalak, Purgato, Rojas-García, Uphoff, McMullen, Foss, Pachya, Rashidian, Borghesani, Henschke, Chong and Lewin2021). The characteristics of BIs (e.g., short, opportunistically target drinkers who are not seeking help for their drinking problems) make them a particularly appealing choice for task-sharing in low-resource settings.

Working with families

Families are adversely affected by AUDs, and they also play a critical role in the development of, as well as recovery from, AUDs (Copello et al., Reference Copello, Copello, Velleman and Templeton2005). Additionally, in LMICs, traditional family structures, prevailing stigma around AUDs, and cultural beliefs held by family members can influence help-seeking, and also negatively influence recovery processes (Kumar et al., Reference Kumar, Schess, Velleman and Nadkarni2022).

Hence, the involvement of family members in the treatment of AUDs, especially in socio-centric LMICs, is critical. The engagement with family members can be through three pathways: (1) working with family members to promote the entry and engagement of the person with AUD into treatment; (2) joint involvement of family members and drinker in the treatment of the latter and (3) interventions responding to the needs of the family members in their own right. Although most of these interventions are from the developed world (e.g., Community Reinforcement Approach and Family Training [CRAFT] (Archer et al., Reference Archer, Harwood, Stevelink, Rafferty and Greenberg2020), the limited evidence on interventions for or involving families in LMIC indicates the benefits of such interventions to the family and leads to better overall outcomes (Rane et al., Reference Rane, Church, Bhatia, Orford, Velleman and Nadkarni2017).

Case study 4 describes a trial from India in which a dyadic relapse prevention (DRP) was compared with usual care as well as individual relapse prevention in men with alcohol dependence (Nattala et al., Reference Nattala, Leung, Nagarajaiah and Murthy2010).

Case study 4: The dyadic relapse prevention (DRP) sessions were interactive, with both the family member and patient participating actively in various practice exercises. These included identifying drinking triggers in the participants and formulating a plan of action to deal with triggers, participating in role-playing, such as the rehearsal of drink refusal skills, practising problem-solving techniques, and providing family members with skills related to supporting abstinence. The dyads attended 8–10 (2–3 per week) sessions, with each session lasting for approximately an hour. The DRP was demonstrated to be superior to usual care as well as individual relapse prevention in reducing drinking behaviours and other outcomes such as family problems.

Digital interventions

More than 80% of the population in many low-income countries in Africa, Central America, and South Asia have mobile phone subscriptions; and mobile devices account for 66–82% of web traffic in LMICs such as India, Indonesia, Nigeria, and South Africa (Naslund et al., Reference Naslund, Aschbrenner, Araya, Marsch, Unützer, Patel and Bartels2017). This increasing affordability and accessibility of digital technologies in LMICs allows for an unique opportunity to harness the advances in these technologies to increase access to care.

There is emerging evidence from a range of LMICs demonstrating the role of digital technologies in diverse interventions for AUDs. This includes an online course to enhance health professionals’ knowledge about the clinical management of alcohol misuse (Pereira et al., Reference Pereira, Wen and Tavares2015), telephone-based brief motivational intervention for reducing alcohol consumption (Wongpakaran et al., Reference Wongpakaran, Petcharaj, Wongpakaran, Sombatmai, Boripuntakul, Intarakamhaeng and Wannarit2011; Signor et al., Reference Signor, Pierozan, Ferigolo, Fernandes, Mazoni and Barros2013), online self-help programme for reducing alcohol consumption among harmful or hazardous users (Andrade et al., Reference Andrade, de Lacerda, Gomide, Ronzani, Sartes, Martins, Bedendo, Souza-Formigoni, Vromans and Poznyak2016) and an online motivational intervention for preventing general substance misuse (de Oliveira Christoff and Boerngen-Lacerda, Reference de Oliveira Christoff and Boerngen-Lacerda2015). Case study 5 describes the innovative use of technology to increase access to relevant training which would allow for appropriate care for AUD to be delivered in primary care.

Case study 5: Project Extension for Community Healthcare Outcomes (ECHO) is a technology-enabled training model which has demonstrated successful outcomes globally in the management of hepatitis, chronic pain, mental health problems, and substance use disorders (Arora et al., Reference Arora, Kalishman, Thornton, Dion, Murata, Deming, Parish, Brown, Komaromy and Colleran2010; Katzman et al., Reference Katzman, Comerci, Boyle, Duhigg, Shelley, Olivas, Daitz, Carroll, Som and Monette2014; Komaromy et al., Reference Komaromy, Duhigg, Metcalf, Carlson, Kalishman, Hayes, Burke, Thornton and Arora2016; Sockalingam et al., Reference Sockalingam, Arena, Serhal, Mohri, Alloo and Crawford2018). In India, an innovative, blended training program was developed to upskill primary healthcare providers and improve compliance to AUD management (Mahadevan et al., Reference Mahadevan, Shukla, Chand, Komaromy, Murthy and Arora2020). An on-site training was complemented with videoconferencing (referred to as tele-ECHO clinics) in this program. This model facilitated easy communication between the primary care providers and the specialists using smartphones or laptops. Significant improvements were found in self-reported compliance to AUD management. This model provides the opportunity to use telementoring for providing specialised care to underserved populations and in resource-constrained settings.

Interventions leveraging digital technology will have a particularly key role in reaching individuals with AUDs in conflict zones and other hard to reach areas, and young people (nearly 90% of whom live in LMICs; UNFPA, 2014) who do not typically access clinical services but are quick to adopt new technologies. Finally, digital technologies have the potential to empower individuals with AUDs and their families to take charge of their own care and to support each other, overcoming barriers such as international borders and time zones. However, digital technology-enabled interventions for AUDs in LMICs are an emerging field, and more rigorous research is needed to evaluate the benefits of these interventions.

Discussion

Despite the high burden of AUDs in LMICs, access to adequate and evidence-based care remains limited. There is evidence – substantial from HICs and emerging from LMICs – of a range of strategies that can be deployed to overcome access barriers and increase the penetration and coverage of interventions for AUDs even in resource-limited settings. These include designing local and culturally acceptable interventions, health systems strengthening through collaborative stepped care and task-sharing, horizontal integration of care into existing priority healthcare platforms, working with families and leveraging digital technologies. Despite the availability of such solutions, there is a long way to go and much to achieve before the treatment gap for AUDs can be reduced, both globally in general, and in LMICs in particular.

Although there is now a strong evidence base describing barriers to treatment access, the great majority of these studies have been carried out in high-income settings. More research is clearly needed to understand which of these are the most common in LMICs, as they are often influenced by contextual factors such as explanatory models and socio-economic factors, such as poverty and access to social welfare benefits. In summary, our understanding of barriers to care for AUDs in LMICs is still rather limited, and further high-quality research is needed to examine the contextual forces that drive access to treatment.

Services for people affected by AUDs need to be based on robust research evidence. Translation of research evidence into change in practice takes time (it takes 17 years for just 14% of original research to benefit practice) and the effects of interventions tested in rigorous trials are diluted when implemented at scale (Balas and Boren, Reference Balas and Boren2000; Parry et al., Reference Parry, Carson-Stevens, Luff, McPherson and Goldmann2013). Much of the failure of the trial effectiveness of an intervention to translate into equivalent outcomes in the real world is due to the complex and relatively uncontrollable nature of the systems within which it has to be implemented (De Savigny and Adam, Reference De Savigny and Adam2009). Hence, research needs to move beyond testing interventions for AUDs in highly controlled conditions to addressing questions of implementation, including strategies that address the systems within which the intervention is delivered, the regulatory and funding environment, the political milieu that influences health service delivery, and societal explanatory models that affect access to care (De Silva and Ryan, Reference De Silva and Ryan2016).

Alcohol use is complex and acts both as a mediating factor in the causal chain linking social determinants (e.g., poverty) to a range of end-point health conditions and outcomes (e.g., tuberculosis), and has its own, direct end-point health conditions as well, that is, AUDs. Additionally, alcohol use disproportionately impacts the poor and marginalised through its interaction with malnutrition and other aspects of living situations, such as overcrowding. Finally, alcohol use can lead to inequitable and differential social and economic consequences, including loss of earnings, unemployment, family disruptions, and interpersonal violence (Schmidt et al., Reference Schmidt, Mäkelä, Rehm and Room2010). Responsiveness to these complexities associated with AUDs require new models of care such as ‘differentiated service delivery’ (DSD), an approach used for HIV care (Ehrenkranz et al., Reference Ehrenkranz, Grimsrud and Rabkin2019). DSD is a person-centred approach which tailors services to the specific needs of diverse groups of people. This includes more-intensive care for groups such as those naïve to treatment and those needing frequent follow-up; and less-intensive approaches for those doing well on treatment and requiring less frequent visits to health facilities. Thus, DSD places the patient at the centre of service delivery; and is a potentially suitable model for AUD care as those with AUDs include a heterogenous group with a range of conditions of varying severities, co-morbidities and diverse needs.

Historically, interventions for AUDs in LMICs have focussed on tertiary treatments and neglected promotion and prevention efforts. The latter is particularly crucial when targeting young people to delay or prevent the initiation of alcohol use. Universal prevention approaches include policy interventions primarily focused on universally reducing access to alcohol use and related injuries and harms. Examples of such policies include pricing of alcohol, as there is a consistent moderately strong association between higher taxes on alcohol and lower heavy drinking, restrictions on ‘happy hours’ which is effective in reducing heavy drinking in some populations such as college students, restrictions on the hours of operation of premises that sell alcohol which have been particularly effective in reducing alcohol-related traffic accidents, restrictions on alcohol outlet density, stringent and consistent application of drunk driving laws, and zero-tolerance laws for underage drinkers (Sher et al., Reference Sher, Talley, Littlefield, Martinez and Friedman2011). In addition, promotion and prevention strategies can be delivered in settings such as schools as well as across communities. Some components of community-based approaches, albeit with modest effectiveness, include media campaigns, citizen monitoring, youth outreach programs, and server training programs (Sher et al., Reference Sher, Talley, Littlefield, Martinez and Friedman2011). Finally, selective approaches are especially critical in high-risk populations such as young people and include strategies such as social norms marketing (provision of information to correct misperceptions regarding peer drinking behaviour), expectancy challenge interventions (provision of accurate information to correct misperceptions of alcohol’s effects), and harm reduction approaches to avoid excessive consumption and to minimise harmful consequences of intoxication such as drinking moderation skills and behavioural alternatives to high-risk alcohol-related behaviours (Sher et al., Reference Sher, Talley, Littlefield, Martinez and Friedman2011).

Evidence of prevention strategies from LMICs is limited and primarily focused on increased taxation of alcohol, bans on alcohol advertising, restrictions on access to alcohol, and enforcement of drinking and driving legislation (Petersen et al., Reference Petersen, Evans-Lacko, Semrau, Barry, Chisholm, Gronholm, Egbe and Thornicroft2016). However, in LMICs, raising taxes is less effective if there are low levels of alcohol consumption, surrogate advertising is commonly used to market alcohol, and regulations to reduce access are ineffective when alcohol can be easily acquired through the unregulated market or brewed at home (Petersen et al., Reference Petersen, Evans-Lacko, Semrau, Barry, Chisholm, Gronholm, Egbe and Thornicroft2016).

Finally, some additional key points that need to be addressed in future research and program implementation in LMICs include testing of interventions for multiple/polysubstance use and for AUDs comorbid with mental health conditions such as depression, evaluation of policy interventions such as increased taxation on alcohol, focus on special populations (e.g., adolescents, pregnant women, indigenous groups) with AUDs, building capacity for AUD care planning and practice, increased multi-sectoral collaboration, and user-involvement and co-production approaches in designing and implementing services for AUD.

Our review has some limitations which are inherent to literature reviews. Unlike a systematic review, our literature review is not replicable as it did not follow a predefined and fixed methodology. There is a potential for selection bias as included studies may not be representative of the entire evidence base. Finally, we did not conduct a quality appraisal of included studies and treated all evidence as equally valid. Despite these limitations, a literature review such as this may sometimes be the best methodological tool especially when the aim is to provide an overview of a certain topic, to examine the state of knowledge on that particular topic, and to identify gaps in research (Snyder, Reference Snyder2019).

Conclusion

Reduction of the treatment gap for AUDs in LMICs needs to be built on a foundation where there is emphasis on evidence-based decision-making, responsiveness to context and culture, and shared ownership and contributions from a range of stakeholders. This will require innovative thinking, leadership, and harnessing of synergies across multiple sectors, framing of treatment for AUDs as a public health and social development priority, and leveraging political will to support sustainable change.

Open peer review

To view the open peer review materials for this article, please visit http://doi.org/10.1017/gmh.2022.57.

Data availability statement

Data availability is not applicable to this article as no new data were created or analysed in this study.

Author contributions

A.N. conceptualised the structure of the review. U.B., R.V., and Y.G. contributed to refining it. A.N. drafted the review with support from U.B. and Y.G. U.B., Y.G., and R.V. reviewed the draft and provided critical feedback. All authors approved the final version of the manuscript. All authors agree to be accountable for all aspects of the review including its accuracy and integrity.

Financial support

This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.

Competing interests

The authors declare no computing interests exist.

References

Ahmadi, J, Babaeebeigi, M, Maany, I, Porter, J, Mohagheghzadeh, M, Ahmadi, N and Dehbozorgi, G (2004) Naltrexone for alcohol-dependent patients. Irish Journal of Medical Science 173(1), 3437.CrossRefGoogle ScholarPubMed
Aira, T, Wang, W, Riedel, M and Witte, SS (2013) Reducing risk behaviors linked to noncommunicable diseases in Mongolia: A randomized controlled trial. American Journal of Public Health 103(9), 16661674.CrossRefGoogle ScholarPubMed
Alaniz, ML (1998) Alcohol availability and targeted advertising in racial/ethnic minority communities. Alcohol Health and Research World 22(4), 286.Google ScholarPubMed
Andrade, ALM, de Lacerda, RB, Gomide, HP, Ronzani, TM, Sartes, LMA, Martins, LF, Bedendo, A, Souza-Formigoni, MLO, Vromans, IS and Poznyak, V (2016) Web-based self-help intervention reduces alcohol consumption in both heavy-drinking and dependent alcohol users: A pilot study. Addictive Behaviors 63, 6371.CrossRefGoogle ScholarPubMed
Archer, J, Bower, P, Gilbody, S, Lovell, K, Richards, D, Gask, L, Dickens, C and Coventry, P (2012) Collaborative care for depression and anxiety problems. Cochrane Database of Systematic Reviews 10, CD006525.Google ScholarPubMed
Archer, M, Harwood, H, Stevelink, S, Rafferty, L and Greenberg, N (2020) Community reinforcement and family training and rates of treatment entry: A systematic review. Addiction 115(6), 10241037.CrossRefGoogle ScholarPubMed
Arora, S, Kalishman, S, Thornton, K, Dion, D, Murata, G, Deming, P, Parish, B, Brown, J, Komaromy, M and Colleran, K (2010) Expanding access to hepatitis C virus treatment—Extension for community healthcare outcomes (ECHO) project: Disruptive innovation in specialty care. Hepatology 52(3), 11241133.CrossRefGoogle ScholarPubMed
Babor, TF, Stenius, K and Romelsjo, A (2008) Alcohol and drug treatment systems in public health perspective: Mediators and moderators of population effects. International Journal of Methods in Psychiatric Research 17(S1), S50S59.CrossRefGoogle ScholarPubMed
Balas, EA and Boren, SA (2000) Managing clinical knowledge for health care improvement.CrossRefGoogle Scholar
Baldin, YC, Sanudo, A and Sanchez, ZM (2018) Effectiveness of a web-based intervention in reducing binge drinking among nightclub patrons. Revista de Saude Publica 52, 2.CrossRefGoogle ScholarPubMed
Baltieri, DA, Daró, FR, Ribeiro, PL and De Andrade, AG (2008) Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 103(12), 20352044.CrossRefGoogle ScholarPubMed
Barrera, M Jr and Castro, FG (2006) A heuristic framework for the cultural adaptation of interventions.CrossRefGoogle Scholar
Bedendo, A, Ferri, CP, de Souza, AAL, Andrade, ALM and Noto, AR (2019) Pragmatic randomized controlled trial of a web-based intervention for alcohol use among Brazilian college students: Motivation as a moderating effect. Drug and Alcohol Dependence 199, 92100.CrossRefGoogle ScholarPubMed
Bedendo, A, McCambridge, J, Gaume, J, Souza, AA, Formigoni, MLO and Noto, AR (2020) Components evaluation of a web‐based personalized normative feedback intervention for alcohol use among college students: A pragmatic randomized controlled trial with a dismantling design. Addiction 115(6), 10631074.CrossRefGoogle Scholar
Benegal, V, Chand, PK and Obot, IS (2009) Packages of care for alcohol use disorders in low-and middle-income countries. PLoS Medicine 6(10), e1000170.CrossRefGoogle ScholarPubMed
Boggio, PS, Sultani, N, Fecteau, S, Merabet, L, Mecca, T, Pascual-Leone, A, Basaglia, A and Fregni, F (2008) Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: A double-blind, sham-controlled study. Drug and Alcohol Dependence 92(1–3), 5560.CrossRefGoogle ScholarPubMed
Bolton, P, Lee, C, Haroz, EE, Murray, L, Dorsey, S, Robinson, C, Ugueto, AM and Bass, J (2014) A transdiagnostic community-based mental health treatment for comorbid disorders: Development and outcomes of a randomized controlled trial among Burmese refugees in Thailand. PLoS Medicine 11(11), e1001757.CrossRefGoogle ScholarPubMed
Borsari, B and Carey, KB (2001) Peer influences on college drinking: A review of the research. Journal of Substance Abuse 13(4), 391424.CrossRefGoogle ScholarPubMed
Bracke, P, Delaruelle, K and Verhaeghe, M (2019) Dominant cultural and personal stigma beliefs and the utilization of mental health services: A cross-national comparison. Frontiers in Sociology 4, 40.CrossRefGoogle ScholarPubMed
Carvalho, AF, Heilig, M, Perez, A, Probst, C and Rehm, J (2019) Alcohol use disorders. The Lancet 394(10200), 781792. doi:10.1016/S0140-6736(19)31775-1.CrossRefGoogle ScholarPubMed
Center for Substance Abuse Treatment (1999) Introduction to brief interventions and therapies. Brief Interventions and Brief Therapies for Substance Abuse. Substance Abuse and Mental Health Services Administration (US).Google Scholar
Chaudhury, S, Brown, FL, Kirk, CM, Mukunzi, S, Nyirandagijimana, B, Mukandanga, J, Ukundineza, C, Godfrey, K, Ng, LC and Brennan, RT (2016) Exploring the potential of a family-based prevention intervention to reduce alcohol use and violence within HIV-affected families in Rwanda. AIDS Care 28(supp2), 118129.CrossRefGoogle ScholarPubMed
Chhabra, R, Springer, C, Leu, C-S, Ghosh, S, Sharma, SK and Rapkin, B (2010) Adaptation of an alcohol and HIV school-based prevention program for teens. AIDS and Behavior 14(1), 177184.CrossRefGoogle ScholarPubMed
Collins, SE (2016) Associations between socioeconomic factors and alcohol outcomes. Alcohol Research: Current Reviews 38(1), 83.Google ScholarPubMed
Connery, HS, McHugh, RK, Reilly, M, Shin, S and Greenfield, SF (2020) Substance use disorders in global mental health delivery: Epidemiology, treatment gap, and implementation of evidence-based treatments. Harvard Review of Psychiatry 28(5), 316.CrossRefGoogle ScholarPubMed
Copello, AG, Copello, AG, Velleman, RD and Templeton, LJ (2005) Family interventions in the treatment of alcohol and drug problems. Drug and Alcohol Review 24(4), 369385.CrossRefGoogle ScholarPubMed
Cubbins, LA, Kasprzyk, D, Montano, D, Jordan, LP and Woelk, G (2012) Alcohol use and abuse among rural Zimbabwean adults: A test of a community-level intervention. Drug and Alcohol Dependence 124(3), 333339.CrossRefGoogle ScholarPubMed
da Silva, MC, Conti, CL, Klauss, J, Alves, LG, do Nascimento Cavalcante, HM, Fregni, F, Nitsche, MA and Nakamura-Palacios, EM (2013) Behavioral effects of transcranial direct current stimulation (tDCS) induced dorsolateral prefrontal cortex plasticity in alcohol dependence. Journal of Physiology-Paris 107(6), 493502.CrossRefGoogle ScholarPubMed
Daengthoen, L, Saengcharnchai, P, Yingwiwattanapong, J and Perngparn, U (2014) Effects of the Phramongkutklao model on alcohol-dependent patient: A randomized controlled trial. Journal of Substance Use 19(1–2), 8188.CrossRefGoogle Scholar
Davies, T and Lund, C (2017) Integrating mental health care into primary care systems in low-and middle-income countries: Lessons from PRIME and AFFIRM. Global Mental Health 4, e7.CrossRefGoogle ScholarPubMed
de Oliveira Christoff, A and Boerngen-Lacerda, R (2015) Reducing substance involvement in college students: A three-arm parallel-group randomized controlled trial of a computer-based intervention. Addictive Behaviors 45, 164171.CrossRefGoogle Scholar
De Savigny, D and Adam, T (2009) Systems Thinking for Health Systems Strengthening. Geneva: World Health Organization.Google Scholar
De Silva, MJ and Ryan, G (2016) Global mental health in 2015: 95% implementation. The Lancet Psychiatry 3(1), 1517.CrossRefGoogle ScholarPubMed
Degenhardt, L, Charlson, F, Ferrari, A, Santomauro, D, Erskine, H, Mantilla-Herrara, A, Whiteford, H, Leung, J, Naghavi, M and Griswold, M (2018) The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: A systematic analysis for the global burden of disease study 2016. The Lancet Psychiatry 5(12), 9871012.CrossRefGoogle Scholar
Doron, A (2010) The intoxicated poor: Alcohol, morality and power among the boatmen of Banaras. South Asian History and Culture 1(2), 282300.CrossRefGoogle Scholar
Edlund, MJ, Unützer, J and Curran, GM (2006) Perceived need for alcohol, drug, and mental health treatment. Social Psychiatry and Psychiatric Epidemiology 41(6), 480487.CrossRefGoogle ScholarPubMed
Ehrenkranz, P, Grimsrud, A and Rabkin, M (2019) Differentiated service delivery: Navigating the path to scale. Current Opinion in HIV and AIDS 14(1), 6065.CrossRefGoogle ScholarPubMed
Evans-Lacko, S, Aguilar-Gaxiola, S, Al-Hamzawi, A, Alonso, J, Benjet, C, Bruffaerts, R, Chiu, W, Florescu, S, de Girolamo, G and Gureje, O (2018) Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: Results from the WHO world mental health (WMH) surveys. Psychological Medicine 48(9), 15601571.CrossRefGoogle ScholarPubMed
Franco, S (2015) Tackling Harmful Alcohol Use Economics and Public Health Policy: Economics and Public Health Policy. Paris: OECD.Google Scholar
Furieri, FA and Nakamura-Palacios, EM (2007) Gabapentin reduces alcohol consumption and craving: A randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry 68(11), 7571.CrossRefGoogle ScholarPubMed
Ghosh, A, Singh, P, Das, N, Pandit, PM, Das, S and Sarkar, S (2022) Efficacy of brief intervention for harmful and hazardous alcohol use: A systematic review and meta-analysis of studies from low middle-income countries. Addiction 117(3), 545558.CrossRefGoogle ScholarPubMed
Gruenewald, PJ, Ponicki, WR and Holder, HD (1993) The relationship of outlet densities to alcohol consumption: A time series cross‐sectional analysis. Alcoholism: Clinical and Experimental Research 17(1), 3847.CrossRefGoogle ScholarPubMed
Gruenewald, PJ, Remer, L and Lipton, R (2002) Evaluating the alcohol environment: Community geography and alcohol problems. Alcohol Research & Health 26(1), 42.Google ScholarPubMed
Gupta, M, Verma, P, Rastogi, R, Arora, S and Elwadhi, D (2017) Randomized open-label trial of baclofen for relapse prevention in alcohol dependence. The American Journal of Drug and Alcohol Abuse 43(3), 324331.CrossRefGoogle ScholarPubMed
Hai, AH, Lee, CS, Abbas, BT, Bo, A, Morgan, H and Delva, J (2021) Culturally adapted evidence-based treatments for adults with substance use problems: A systematic review and meta-analysis. Drug and Alcohol Dependence 226, 108856.CrossRefGoogle ScholarPubMed
Heather, N (2010) Breaking new ground in the study and practice of alcohol brief interventions. Drug and Alcohol Review 29, 584588. doi:10.1111/j.1465-3362.2010.00204.x.CrossRefGoogle Scholar
Jacob, KS and Patel, V (2014) Classification of mental disorders: A global mental health perspective. The Lancet 383(9926), 14331435.CrossRefGoogle ScholarPubMed
Jordans, MJD, Luitel, NP, Garman, E, Kohrt, BA, Rathod, SD, Shrestha, P, Komproe, IH, Lund, C and Patel, V (2019) Effectiveness of psychological treatments for depression and alcohol use disorder delivered by community-based counsellors: Two pragmatic randomised controlled trials within primary healthcare in Nepal. The British Journal of Psychiatry: the Journal of Mental Science 215(2), 485493. doi:10.1192/bjp.2018.300.CrossRefGoogle ScholarPubMed
Joseph, J and Basu, D (2017) Efficacy of brief interventions in reducing hazardous or harmful alcohol use in middle-income countries: Systematic review of randomized controlled trials. Alcohol and Alcoholism 52(1), 5664.CrossRefGoogle ScholarPubMed
Kakuma, R, Minas, H, van Ginneken, N, Dal Poz, MR, Desiraju, K, Morris, JE, Saxena, S and Scheffler, RM (2011) Human resources for mental health care: Current situation and strategies for action. The Lancet 378(9803), 16541663.CrossRefGoogle ScholarPubMed
Kalichman, SC, Simbayi, LC, Vermaak, R, Cain, D, Smith, G, Mthebu, J and Jooste, S (2008) Randomized trial of a community-based alcohol-related HIV risk-reduction intervention for men and women in Cape Town South Africa. Annals of Behavioral Medicine 36(3), 270279.CrossRefGoogle ScholarPubMed
Kamal, K, Sunita, S, Karobi, D and Abhishek, G (2020) Nurse-delivered screening and brief intervention among college students with hazardous alcohol use: A double-blind randomized clinical trial from India. Alcohol and Alcoholism 55(3), 284290.CrossRefGoogle ScholarPubMed
Katzman, JG, Comerci, G, Boyle, JF, Duhigg, D, Shelley, B, Olivas, C, Daitz, B, Carroll, C, Som, D and Monette, R (2014) Innovative telementoring for pain management: Project ECHO pain. Journal of Continuing Education in the Health Professions 34(1), 6875.CrossRefGoogle ScholarPubMed
Kessler, RC, Aguilar-Gaxiola, S, Alonso, J, Chatterji, S, Lee, S and Üstün, TB (2009) The WHO world mental health (WMH) surveys. Die Psychiatrie 6(01), 59.Google ScholarPubMed
Klauss, J, Penido Pinheiro, LC, Silva Merlo, BL, Correia Santos, GA, Fregni, F, Nitsche, MA and Miyuki Nakamura-Palacios, E (2014) A randomized controlled trial of targeted prefrontal cortex modulation with tDCS in patients with alcohol dependence. International Journal of Neuropsychopharmacology 17(11), 17931803.CrossRefGoogle ScholarPubMed
Kodner, DL and Spreeuwenberg, C (2002) Integrated care: Meaning, logic, applications, and implications – a discussion paper. International Journal of Integrated Care 2, e12.CrossRefGoogle ScholarPubMed
Kohn, R, Saxena, S, Levav, I and Saraceno, B (2004) The treatment gap in mental health care. Bulletin of the World Health Organization 82(11), 858866.Google ScholarPubMed
Komaromy, M, Duhigg, D, Metcalf, A, Carlson, C, Kalishman, S, Hayes, L, Burke, T, Thornton, K and Arora, S (2016) Project ECHO (extension for community healthcare outcomes): A new model for educating primary care providers about treatment of substance use disorders. Substance Abuse 37(1), 2024.CrossRefGoogle ScholarPubMed
Kumar, S, Schess, J, Velleman, R and Nadkarni, A (2022) Stigma towards dependent drinking and its role on caregiving burden: A qualitative study from Goa, India. Drug and Alcohol Review 41(4), 778786.CrossRefGoogle Scholar
Kumpfer, KL, Pinyuchon, M, de Melo, AT and Whiteside, HO (2008) Cultural adaptation process for international dissemination of the strengthening families program. Evaluation & the Health Professions 31(2), 226239.CrossRefGoogle ScholarPubMed
Leddy, AM, Hahn, JA, Getahun, M, Emenyonu, NI, Woolf-King, SE, Sanyu, N, Katusiime, A, Fatch, R, Chander, G and Hutton, HE (2021) Cultural adaptation of an intervention to reduce hazardous alcohol use among people living with HIV in southwestern Uganda. AIDS and Behavior 25(3), 237250.CrossRefGoogle ScholarPubMed
Levin, C and Chisholm, D (2016) Cost-effectiveness and affordability of interventions, policies, and platforms for the prevention and treatment of mental, neurological, and substance use disorders. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities 4(3), 219236.Google Scholar
Likhitsathian, S, Uttawichai, K, Booncharoen, H, Wittayanookulluk, A, Angkurawaranon, C and Srisurapanont, M (2013) Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: A 12-week, randomized, placebo-controlled trial. Drug and Alcohol Dependence 133(2), 440446.CrossRefGoogle ScholarPubMed
Luitel, NP, Jordans, MJD, Kohrt, BA, Rathod, SD and Komproe, IH (2017) Treatment gap and barriers for mental health care: A cross-sectional community survey in Nepal. PLoS One 12(8), e0183223. doi:10.1371/journal.pone.0183223.CrossRefGoogle ScholarPubMed
Madhombiro, M, Kidd, M, Dube, B, Dube, M, Mutsvuke, W, Muronzie, T, Zhou, DT, Derveeuw, S, Chibanda, D and Chingono, A (2020) Effectiveness of a psychological intervention delivered by general nurses for alcohol use disorders in people living with HIV in Zimbabwe: A cluster randomized controlled trial. Journal of the International AIDS Society 23(12), e25641.CrossRefGoogle ScholarPubMed
Mahadevan, J, Shukla, L, Chand, PK, Komaromy, M, Murthy, P and Arora, S (2020) Innovative virtual mentoring using the extension for community healthcare outcomes model for primary care providers for the management of alcohol use disorders. The Indian Journal of Medical Research 151(6), 609.Google ScholarPubMed
Manthey, J, Hassan, SA, Carr, S, Kilian, C, Kuitunen-Paul, S and Rehm, J (2021) What are the economic costs to society attributable to alcohol use? A systematic review and modelling study. PharmacoEconomics 39(7), 809822.CrossRefGoogle ScholarPubMed
Marsiglia, FF, Kulis, SS, Booth, JM, Nuño-Gutierrez, BL and Robbins, DE (2015) Long-term effects of the keepin’it REAL model program in Mexico: Substance use trajectories of Guadalajara middle school students. The Journal of Primary Prevention 36(2), 93104.CrossRefGoogle ScholarPubMed
Martin, SE (2001) The links between alcohol, crime and the criminal justice system: Explanations, evidence and interventions. American Journal on Addictions 10(2), 136158.CrossRefGoogle ScholarPubMed
McKleroy, VS, Galbraith, JS, Cummings, B, Jones, P, Harshbarger, C, Collins, C, Gelaude, D, Carey, JW and ADAPT Team (2006) Adapting evidence–based behavioral interventions for new settings and target populations. AIDS Education & Prevention 18(supp), 5973.CrossRefGoogle ScholarPubMed
Mekonen, T, Chan, GC, Connor, J, Hall, W, Hides, L and Leung, J (2021) Treatment rates for alcohol use disorders: A systematic review and meta‐analysis. Addiction 116(10), 26172634.CrossRefGoogle ScholarPubMed
Merkouris, SS, Rodda, SN and Dowling, NA (2022) Affected other interventions: A systematic review and meta‐analysis across addictions. Addiction 117(9), 23932414.CrossRefGoogle Scholar
Mertens, JR, Ward, CL, Bresick, GF, Broder, T and Weisner, CM (2014) Effectiveness of nurse-practitioner-delivered brief motivational intervention for young adult alcohol and drug use in primary care in South Africa: A randomized clinical trial. Alcohol and Alcoholism 49(4), 430438.CrossRefGoogle ScholarPubMed
Myers, B, Stein, DJ, Mtukushe, B and Sorsdahl, K (2012) Feasibility and acceptability of screening and brief interventions to address alcohol and other drug use among patients presenting for emergency services in Cape Town, South Africa. Advances in Preventive Medicine 2012, 569153.CrossRefGoogle ScholarPubMed
Nadkarni, A, Velleman, R, Dabholkar, H, Shinde, S, Bhat, B, McCambridge, J, Murthy, P, Wilson, T, Weobong, B and Patel, V (2015) The systematic development and pilot randomized evaluation of counselling for alcohol problems, a lay Counselor‐delivered psychological treatment for harmful drinking in primary Care in India: The PREMIUM study. Alcoholism: Clinical and Experimental Research 39(3), 522531.CrossRefGoogle ScholarPubMed
Nadkarni, A, Weiss, HA, Weobong, B, McDaid, D, Singla, DR, Park, AL, Bhat, B, Katti, B, McCambridge, J, Murthy, P, King, M, Wilson, GT, Kirkwood, B, Fairburn, CG, Velleman, R and Patel, V (2017a) Sustained effectiveness and cost-effectiveness of counselling for alcohol problems, a brief psychological treatment for harmful drinking in men, delivered by lay counsellors in primary care: 12-month follow-up of a randomised controlled trial. PLoS Medicine 14(9), e1002386. doi:10.1371/journal.pmed.1002386.CrossRefGoogle ScholarPubMed
Nadkarni, A, Weobong, B, Weiss, HA, McCambridge, J, Bhat, B, Katti, B, Murthy, P, King, M, McDaid, D, Park, AL, Wilson, GT, Kirkwood, B, Fairburn, CG, Velleman, R and Patel, V (2017b) Counselling for alcohol problems (CAP), a lay counsellor-delivered brief psychological treatment for harmful drinking in men, in primary care in India: A randomised controlled trial. Lancet 389(10065), 186195. doi:10.1016/s0140-6736(16)31590-2.CrossRefGoogle Scholar
Nalwadda, O, Rathod, SD, Nakku, J, Lund, C, Prince, M and Kigozi, F (2018) Alcohol use in a rural district in Uganda: Findings from community-based and facility-based cross-sectional studies. International Journal of Mental Health Systems 12(1), 110.CrossRefGoogle Scholar
Naslund, JA, Aschbrenner, KA, Araya, R, Marsch, LA, Unützer, J, Patel, V and Bartels, S (2017) Digital technology for treating and preventing mental disorders in low-income and middle-income countries: A narrative review of the literature. Lancet Psychiatry 4(6), 486500.CrossRefGoogle ScholarPubMed
Nattala, P, Leung, KS, Nagarajaiah, and Murthy, P (2010) Family member involvement in relapse prevention improves alcohol dependence outcomes: A prospective study at an addiction treatment facility in India. Journal of Studies on Alcohol and Drugs 71(4), 581587.CrossRefGoogle ScholarPubMed
Noknoy, S, Rangsin, R, Saengcharnchai, P, Tantibhaedhyangkul, U and McCambridge, J (2010) RCT of effectiveness of motivational enhancement therapy delivered by nurses for hazardous drinkers in primary care units in Thailand. Alcohol & Alcoholism 45(3), 263270.CrossRefGoogle ScholarPubMed
Orford, J, Velleman, R, Natera, G, Templeton, L and Copello, A (2013) Addiction in the family is a major but neglected contributor to the global burden of adult ill-health. Social Science & Medicine 78, 7077.CrossRefGoogle Scholar
Papas, RK, Gakinya, BN, Mwaniki, MM, Lee, H, Keter, AK, Martino, S, Klein, DA, Liu, T, Loxley, MP, Sidle, JE, Schlaudt, K, Nafula, T, Omodi, VM, Baliddawa, JB, Kinyanjui, DW and Maisto, SA (2021) A randomized clinical trial of a group cognitive–behavioral therapy to reduce alcohol use among human immunodeficiency virus-infected outpatients in western Kenya. Addiction 116(2), 305318. doi:10.1111/add.15112.CrossRefGoogle ScholarPubMed
Papas, RK, Sidle, JE, Martino, S, Baliddawa, JB, Songole, R, Omolo, OE, Gakinya, BN, Mwaniki, MM, Adina, JO and Nafula, T (2010) Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western Kenya. AIDS and Behavior 14(3), 669678.CrossRefGoogle ScholarPubMed
Parry, GJ, Carson-Stevens, A, Luff, DF, McPherson, ME and Goldmann, DA (2013) Recommendations for evaluation of health care improvement initiatives. Academic Pediatrics 13(6), S23S30.CrossRefGoogle ScholarPubMed
Patel, V, Chisholm, D, Dua, T, Laxminarayan, R and Medina-Mora, M (2016) Global burden of mental, neurological, and substance use disorders: An analysis from the global burden of disease study 2010 – Mental, neurological, and substance use disorders: Disease control priorities, vol. 4.Google Scholar
Patel, V, Maj, M, Flisher, AJ, De Silva, MJ, Koschorke, M, Prince, M, Zonal, W, Representatives, MS, Tempier, R, Riba, M and Sanchez, M (2010) Reducing the treatment gap for mental disorders: A WPA survey. World Psychiatry 9(3), 169176.CrossRefGoogle ScholarPubMed
Patel, V, Weiss, HA, Chowdhary, N, Naik, S, Pednekar, S, Chatterjee, S, De Silva, MJ, Bhat, B, Araya, R, King, M, Simon, G, Verdeli, H and Kirkwood, BR (2010) Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): A cluster randomised controlled trial. Lancet 376, 20862095.Google Scholar
Pathare, S, Brazinova, A and Levav, I (2018) Care gap: A comprehensive measure to quantify unmet needs in mental health. Epidemiology and Psychiatric Sciences 27(5), 463467.CrossRefGoogle Scholar
Pengpid, S, Peltzer, K, Van der Heever, H and Skaal, L (2013) Screening and brief interventions for hazardous and harmful alcohol use among university students in South Africa: Results from a randomized controlled trial. International Journal of Environmental Research and Public Health 10(5), 20432057.CrossRefGoogle ScholarPubMed
Pereira, CA, Wen, CL and Tavares, H (2015) Alcohol abuse management in primary care: An e-learning course. Telemedicine and e-Health 21(3), 200206.CrossRefGoogle ScholarPubMed
Perngparn, U, Assanangkornchai, S, Pilley, C and Aramrattana, A (2008) Drug and alcohol services in middle-income countries. Current Opinion in Psychiatry 21(3), 229233.CrossRefGoogle ScholarPubMed
Petersen, I, Evans-Lacko, S, Semrau, M, Barry, MM, Chisholm, D, Gronholm, P, Egbe, CO and Thornicroft, G (2016) Promotion, prevention and protection: Interventions at the population-and community-levels for mental, neurological and substance use disorders in low-and middle-income countries. International Journal of Mental Health Systems 10(1), 113.CrossRefGoogle ScholarPubMed
Probst, C, Roerecke, M, Behrendt, S and Rehm, J (2015) Gender differences in socioeconomic inequality of alcohol‐attributable mortality: A systematic review and meta‐analysis. Drug and Alcohol Review 34(3), 267277.CrossRefGoogle ScholarPubMed
Rabiee, R, Agardh, E, Coates, MM, Allebeck, P and Danielsson, AK (2017) Alcohol–attributed disease burden and alcohol policies in the BRICS–countries during the years 1990–2013. Journal of Global Health 7(1), 010104.CrossRefGoogle ScholarPubMed
Rane, A, Church, S, Bhatia, U, Orford, J, Velleman, R and Nadkarni, A (2017) Psychosocial interventions for addiction-affected families in low and middle income countries: A systematic review. Addictive Behaviors 74, 18. doi:10.1016/j.addbeh.2017.05.015.CrossRefGoogle ScholarPubMed
Rathod, SD, De Silva, MJ, Ssebunnya, J, Breuer, E, Murhar, V, Luitel, NP, Medhin, G, Kigozi, F, Shidhaye, R and Fekadu, A (2016) Treatment contact coverage for probable depressive and probable alcohol use disorders in four low-and middle-income country districts: The PRIME cross-sectional community surveys. PLoS One 11(9), e0162038.CrossRefGoogle ScholarPubMed
Rathod, SD, Nadkarni, A, Bhana, A and Shidhaye, R (2015) Epidemiological features of alcohol use in rural India: A population-based cross-sectional study. BMJ Open 5(12), e009802. doi:10.1136/bmjopen-2015-009802.CrossRefGoogle ScholarPubMed
Rathod, S, Pinninti, N, Irfan, M, Gorczynski, P, Rathod, P, Gega, L and Naeem, F (2017) Mental health service provision in low-and middle-income countries. Health Services Insights 10, 1178632917694350.CrossRefGoogle ScholarPubMed
Rathod, SD, Roberts, T, Medhin, G, Murhar, V, Samudre, S, Luitel, NP, Selohilwe, O, Ssebunnya, J, Jordans, MJ and Bhana, A (2018) Detection and treatment initiation for depression and alcohol use disorders: Facility-based cross-sectional studies in five low-income and middle-income country districts. BMJ Open 8(10), e023421.CrossRefGoogle ScholarPubMed
Rehm, J and Shield, KD (2019) Global burden of disease and the impact of mental and addictive disorders. Current Psychiatry Reports 21(2), 17.CrossRefGoogle ScholarPubMed
Rehm, J, Shield, K, Gmel, G, Rehm, M and Frick, U (2013) Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. European Neuropsychopharmacology 23(2), 8997.CrossRefGoogle ScholarPubMed
Rendall‐Mkosi, K, Morojele, N, London, L, Moodley, S, Singh, C and Girdler‐Brown, B (2013) A randomized controlled trial of motivational interviewing to prevent risk for an alcohol‐exposed pregnancy in the W estern Cape, S outh A frica. Addiction 108(4), 725732.CrossRefGoogle Scholar
Ronzani, TM, Fuentes-Mejía, C, Mota, DCB, Gomide, HP, Ferreira, ML and Cruvinel, E (2019) Intervenções Breves Para o abuso de substâncias na América Latina: Uma revisão sistemática. Psicologia em Estudo 24, e44393.Google Scholar
Rotheram-Borus, MJ, Tomlinson, M, Le Roux, I and Stein, JA (2015) Alcohol use, partner violence, and depression: A cluster randomized controlled trial among urban south African mothers over 3 years. American Journal of Preventive Medicine 49(5), 715725.CrossRefGoogle ScholarPubMed
Samokhvalov, AV, Popova, S, Room, R, Ramonas, M and Rehm, J (2010) Disability associated with alcohol abuse and dependence. Alcoholism: Clinical and Experimental Research 34(11), 18711878CrossRefGoogle ScholarPubMed
Saraceno, B, van Ommeren, M, Batniji, R, Cohen, A, Gureje, O, Mahoney, J, Sridhar, D and Underhill, C (2007) Barriers to improvement of mental health services in low-income and middle-income countries. The Lancet 370(9593), 11641174.CrossRefGoogle ScholarPubMed
Sassi, F (2015) Tackling harmful alcohol use: Economics and public health policy. OECD report.Google Scholar
Schmidt, LA, Mäkelä, P, Rehm, J and Room, R (2010) Alcohol: Equity and social determinants. Equity, Social Determinants and Public Health Programmes 11, 30.Google Scholar
Schwarzinger, M, Thiébaut, SP, Baillot, S, Mallet, V and Rehm, J (2018) Alcohol use disorders and associated chronic disease – a national retrospective cohort study from France. BMC Public Health 18(1), 19.CrossRefGoogle Scholar
Sher, KJ, Talley, AE, Littlefield, AK and Martinez, JA (2011) Alcohol use and alcohol use disorders. In Friedman, H. S. (Ed.), The Oxford handbook of health psychology (pp. 686737). Oxford University Press.CrossRefGoogle Scholar
Shidhaye, R, Lund, C and Chisholm, D (2015) Closing the treatment gap for mental, neurological and substance use disorders by strengthening existing health care platforms: Strategies for delivery and integration of evidence-based interventions. International Journal of Mental Health Systems 9(1), 111.CrossRefGoogle ScholarPubMed
Shifting, WT (2008) Rational Redistribution of Tasks among Health Workforce Teams: Global Recommendations and Guidelines. Geneva: World Health Organization.Google Scholar
Shin, S, Livchits, V, Connery, HS, Shields, A, Yanov, S, Yanova, G, Fitzmaurice, GM, Nelson, AK, Greenfield, SF and Group, TTAW (2013) Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia. Addiction 108(8), 13871396.CrossRefGoogle ScholarPubMed
Signor, L, Pierozan, PS, Ferigolo, M, Fernandes, S, Mazoni, CG and Barros, HMT (2013) Efficacy of the telephone-based brief motivational intervention for alcohol problems in Brazil. Brazilian Journal of Psychiatry 35, 254261.CrossRefGoogle ScholarPubMed
Sileo, KM, Miller, AP, Wagman, JA and Kiene, SM (2021) Psychosocial interventions for reducing alcohol consumption in sub‐Saharan African settings: A systematic review and meta‐analysis. Addiction 116(3), 457473.CrossRefGoogle ScholarPubMed
Smyth, A, Teo, KK, Rangarajan, S, O’Donnell, M, Zhang, X, Rana, P, Leong, DP, Dagenais, G, Seron, P and Rosengren, A (2015) Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: A prospective cohort study. The Lancet 386(10007), 19451954.CrossRefGoogle ScholarPubMed
Snyder, H (2019) Literature review as a research methodology: An overview and guidelines. Journal of Business Research 104, 333339.CrossRefGoogle Scholar
Sockalingam, S, Arena, A, Serhal, E, Mohri, L, Alloo, J and Crawford, A (2018) Building provincial mental health capacity in primary care: An evaluation of a project ECHO mental health program. Academic Psychiatry 42(4), 451457.CrossRefGoogle ScholarPubMed
Sorsdahl, K, Stein, DJ, Corrigall, J, Cuijpers, P, Smits, N, Naledi, T and Myers, B (2015) The efficacy of a blended motivational interviewing and problem solving therapy intervention to reduce substance use among patients presenting for emergency services in South Africa: A randomized controlled trial. Substance Abuse Treatment, Prevention, and Policy 10(1), 46. doi:10.1186/s13011-015-0042-1.CrossRefGoogle ScholarPubMed
Staton, CA, Vissoci, JRN, El-Gabri, D, Adewumi, K, Concepcion, T, Elliott, SA, Evans, DR, Galson, SW, Pate, CT and Reynolds, LM (2022) Patient-level interventions to reduce alcohol-related harms in low-and middle-income countries: A systematic review and meta-summary. PLoS Medicine 19(4), e1003961.CrossRefGoogle ScholarPubMed
Thavorncharoensap, M, Teerawattananon, Y, Yothasamut, J and Lertpitakpong, C (2009) The economic impact of alcohol consumption: A systematic review. Substance Abuse Treatment, Prevention, and Policy 4(1), 111.Google ScholarPubMed
Toesland, F (2016) Alcohol consumption rising in Africa despite obstacles. African Business. Available at https://africanbusinessmagazine.com/sectors/retail/alcohol-consumption-rising-in-africa-despiteobstacles/ (accessed 13 December 2016).Google Scholar
UNFPA (2014) The Power of 1.8 Billion: Adolescents, Youth and the Transformation of the Future, vol. 2014. New York: UNFPA State of the World Population.Google Scholar
van Ginneken, N, Chin, WY, Lim, YC, Ussif, A, Singh, R, Shahmalak, U, Purgato, M, Rojas-García, A, Uphoff, E, McMullen, S, Foss, HS, Pachya, AT, Rashidian, L, Borghesani, A, Henschke, N, Chong, L-Y and Lewin, S (2021) Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries. Cochrane Database of Systematic Reviews 8, CD009149. doi:10.1002/14651858.CD009149.pub3.Google ScholarPubMed
Walls, H, Cook, S, Matzopoulos, R and London, L (2020) Advancing alcohol research in low-income and middle-income countries: A global alcohol environment framework. BMJ Global Health 5(4), e001958.CrossRefGoogle ScholarPubMed
Ward, CL, Mertens, JR, Bresick, GF, Little, F and Weisner, CM (2015) Screening and brief intervention for substance misuse: Does it reduce aggression and HIV-related risk behaviours? Alcohol and Alcoholism 50(3), 302309.CrossRefGoogle ScholarPubMed
Wechsberg, WM, Bonner, CP, Zule, WA, van der Horst, C, Ndirangu, J, Browne, FA, Kline, TL, Howard, BN and Rodman, NF (2019) Addressing the nexus of risk: Biobehavioral outcomes from a cluster randomized trial of the Women’s health CoOp plus in Pretoria, South Africa. Drug and Alcohol Dependence 195, 1626.CrossRefGoogle ScholarPubMed
Westman, J, Wahlbeck, K, Laursen, TM, Gissler, M, Nordentoft, M, Hällgren, J, Arffman, M and Ösby, U (2015) Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden. Acta Psychiatrica Scandinavica 131(4), 297306.CrossRefGoogle ScholarPubMed
Wingood, GM and DiClemente, RJ (2008) The ADAPT-ITT model: A novel method of adapting evidence-based HIV interventions. JAIDS Journal of Acquired Immune Deficiency Syndromes 47, S40S46.CrossRefGoogle Scholar
Wongpakaran, T, Petcharaj, K, Wongpakaran, N, Sombatmai, S, Boripuntakul, T, Intarakamhaeng, D and Wannarit, K (2011) The effect of telephone-based intervention (TBI) in alcohol abusers: A pilot study. Journal of the Medical Association of Thailand 94(7), 849.Google ScholarPubMed
World Health Organization (2014) Global Status Report on Alcohol and Health, vol. 2014. Geneva: World Health Organization.Google Scholar
World Health Organization (2018) Global status report on alcohol and health 2018. Available at https://www.who.int/publications/i/item/9789241565639.Google Scholar
Zewdu, S, Hanlon, C, Fekadu, A, Medhin, G and Teferra, S (2019) Treatment gap, help-seeking, stigma and magnitude of alcohol use disorder in rural Ethiopia. Substance Abuse Treatment, Prevention, and Policy 14(1), 110.CrossRefGoogle ScholarPubMed

Author comment: The environmental impact of data-driven precision medicine initiatives — R1/PR1

Comments

No accompanying comment.

Review: The environmental impact of data-driven precision medicine initiatives — R1/PR2

Conflict of interest statement

I have no conflict of interest to declare.

Comments

Comments to Author: This is well written and an important subject. Well done.

Review: The environmental impact of data-driven precision medicine initiatives — R1/PR3

Conflict of interest statement

Reviewer declares none.

Comments

Comments to Author: The authors addressed the feedback provided by reviewers.

Recommendation: The environmental impact of data-driven precision medicine initiatives — R1/PR4

Comments

No accompanying comment.

Decision: The environmental impact of data-driven precision medicine initiatives — R1/PR5

Comments

No accompanying comment.

Decision: The environmental impact of data-driven precision medicine initiatives — R1/PR6

Comments

No accompanying comment.